Food and Drug Administration (FDA) has released a final guidance clarifying the necessary standards to adopt secure, interoperable electronic data exchange among the pharmaceutical distribution supply chain. Specifically, the DSCSA Standards for the Interoperable Exchange of Information for Tracing of Certain Human, Finished, Prescription Drugs – Guidance for Industry document offers recommendations for trading partners to adopt the Electronic Product Code Information Services standard to manage transaction information and transaction statements. The document finalizes the revisions added to the July 2022-issued document of the same title. The document can be accessed via the Regulatory Information section of FDA’s website.